Results 221 to 230 of about 5,551,009 (351)

Synergistic Mn-MOF Activation of Pistol Ribozymes for Cancer Immunotherapy. [PDF]

Adv Sci (Weinh)
Zhao M, Qiao S, Bai J, Zhang J, Xi Z, Li Z, Zhan X, Zhang Y, Yu X, Chen Y, Liu Y.   +10 more
europepmc   +1 more source

Tertiary lymphoid structures in the era of cancer immunotherapy

Nature Reviews. Cancer, 2019
C. Sautès-Fridman, F. Petitprez, J. Calderaro, W. Fridman   +3 more
semanticscholar   +1 more source

Multimodal Actuation and Environment Adaptive Strategies of Bio‐Inspired Micro/Nanorobots in Precision Medicine

Advanced Robotics Research, EarlyView.
An introduction for multidrive and environment‐adaptive micro/nanorobotics: design and fabrication strategies, intelligent actuation, and their applications. Various intelligent actuation approaches—magnetic, acoustic, optical, chemical, and biological—can be synergistically designed to enhance flexibility and adaptive behavior for precision medicine ...
Aiqing Ma, Han Gong, Jiacheng Ouyang, Liqi Chen, Tianfang Kang, Yiran He, Guojun Huang, Sidi Zheng, Ting Yin, Hong Pan, Lintao Cai   +10 more
wiley   +1 more source

Predictive Role of Baseline Eosinophil Count in Metastatic Melanoma Treated with Nivolumab and Ipilimumab

EJC Skin Cancer
C. Trojaniello, D. Mallardo, V. Vanella, F. Sparano, M.G. Vitale, E. Simeone, L. Festino, A. Facchini, A.L. Marretta, A. Esposito, M. Ottaviano, A. Lagodin D'Amato, B. Alfano, P.A. Ascierto   +13 more
doaj   +1 more source

Targeting erythroid progenitor cell metabolism to enhance cancer immunotherapy. [PDF]

NPJ Precis Oncol
Li ZZ, Huang HL, Li YC, Wang WD, Sun ZJ.
europepmc   +1 more source

Pre‐Encoded IFN‐I Sensitivity Exacerbates Memory T Cell Senescence in Solid Tumors

Advanced Science, EarlyView.
Type I interferon (IFN‐I) signaling promotes p21‐dependent cell cycle arrest in senescent tumor‐specific memory T cells, resulting in poor proliferative responses and solid tumor regression during cancer vaccination. Conversely, IFNα/β receptor blockade reinvigorates T cell proliferation to regress solid tumors and is more effective with increasing ...
Andrew Nguyen, Scott R Walsh, Li Deng, Lan Chen, Yonghong Wan   +4 more
wiley   +1 more source

Magnesium and Cancer Immunotherapy: A Narrative Practical Review. [PDF]

Nutrients
Sambataro D, Scandurra G, Gebbia V, Greco M, Ciminna A, Valerio MR.   +5 more
europepmc   +1 more source

GSH‐Responsive Nanoparticles Enhance Hepatocellular Carcinoma Immunotherapy Through Synergistic Effects of Cuproptosis and PI3K Inhibitor Combination

Advanced Science, EarlyView.
ABSTRACT Cuproptosis, an emerging form of programmed cell death, is capable of inducing mitochondrial dysfunction. Moreover, the PI3K‐AKT‐mTOR signaling pathway contributes to tumor cell progression by reprogramming mitochondrial morphology and function.
Lei Wu, Jintong Na, Xiyu Liu, Dongsheng Tang, Zhungang Yang, Zheng Cao, Xinyue He, Haihua Xiao, Liping Zhong, Yuan Liao, Yongxiang Zhao   +10 more
wiley   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

Advanced Science, EarlyView.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance, Bryan S. Yung, Michael M. Allevato, Marcus M Cheng, Maria F. Camargo, Robert Saddawi‐Konefka, Kanika Dhawan, Ashwyn K. Sharma, Mahsa Mortaja, Sophie Bice, Daniel J. Scanderbeg, Diego Alvarado, Jyoti Mayadev, Ramez N. Eskander, Stephen R. Adams, Pippa F. Cosper, J. Silvio Gutkind, Sunil J. Advani   +17 more
wiley   +1 more source

Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy. [PDF]

Ann Hematol
Al-Khreisat MJ, Abdulsahib WK, Jasim IK, Malathi H, Patro PS, Anand DA, Mukherjee G, Sinha A, Buriyeva D.   +8 more
europepmc   +1 more source